Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients

被引：0
|
作者：
Gomez-Ayerbe, C. [1 ,2 ]
Palacios, R. [1 ,2 ]
Perez, C. [1 ,2 ]
Tellez, F. [3 ]
Sayago, C. [4 ]
Rios, M. J. [5 ]
Martin-Aspas, A. [6 ]
Camacho, A. [7 ]
Munoz, L. [8 ]
Santos, J. [1 ,2 ]
机构：
[1] Hosp Univ Virgen Victoria, Malaga, Spain
[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[3] Hosp Univ Puerto Real, Puerto Real, Spain
[4] Hosp Univ Virgen Valme, Seville, Spain
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Hosp Univ Puerta Mar, Cadiz, Spain
[7] Hosp Univ Reina Sofia, Cordoba, Spain
[8] Hosp Univ San Cecilio, Granada, Spain
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PE37/23
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [21] DIRECT ACTING ANTIVIRALS (DAA) IN CHRONIC HEPATITIS C INFECTION WITH LIVER CIRRHOSIS
    Basharat, Maryam
    Mishal, Mina
    Abbas, Mujahid
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (02): : 4436 - 4440
  • [22] Management of HCV patients with cirrhosis with direct acting antivirals
    Boccaccio, Vincenzo
    Bruno, Savino
    LIVER INTERNATIONAL, 2014, 34 : 38 - 45
  • [23] Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno, Raffaele
    Fagiuoli, Stefano
    Sacchi, Paolo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (09) : 699 - 701
  • [24] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
    Rockstroh, Juergen K.
    LIVER INTERNATIONAL, 2015, 35 : 51 - 55
  • [25] THE AVAILABILITY OF DIRECT ACTING ANTIVIRALS (DAA) IN 2012: A FRENCH MODEL-BASED ANALYSIS OF THE INCREASED NUMBER OF PATIENTS TREATED FOR CHRONIC HCV INFECTION
    Deuffic-Burban, S.
    Mathurin, P.
    Pol, S.
    Larsen, C.
    Roudot-Thoraval, F.
    Desenclos, J-C
    Dhumeaux, D.
    Yazdanpanah, Y.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S539 - S540
  • [26] Reactivation of Occult HBV Infection in Patients Cured of HCV With Direct-Acting Antivirals
    Karen Ma
    Susanne Shokoohi
    Nancy Reau
    Current Treatment Options in Infectious Diseases, 2017, 9 (4) : 380 - 388
  • [27] Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals
    Musolino, Cristina
    Cacciola, Irene
    Tripodi, Gianluca
    Lombardo, Daniele
    Raffa, Giuseppina
    Alibrandi, Angela
    Squadrito, Giovanni
    Raimondo, Giovanni
    Pollicino, Teresa
    ANTIVIRAL THERAPY, 2019, 24 (03) : 187 - 192
  • [28] Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation
    Grottenthaler, Julia M.
    Werner, Christoph R.
    Steurer, Martina
    Spengler, Ulrich
    Berg, Thomas
    Engelmann, Cornelius
    Wedemeyer, Heiner
    von Hahn, Thomas
    Stremmel, Wolfgang
    Pathil, Anita
    Seybold, Ulrich
    Schott, Eckart
    Blessin, Usha
    Sarrazin, Christoph
    Welker, Martin-Walter
    Harrer, Ellen
    Scholten, Stefan
    Hinterleitner, Clemens
    Lauer, Ulrich M.
    Malek, Nisar P.
    Berg, Christoph P.
    PLOS ONE, 2018, 13 (06):
  • [29] Mortality associated with the treatment of HCV with direct-acting antivirals
    Laurain, Anne
    Kramer, Laura
    Sultanik, Philippe
    Vallet-Pichard, Anais
    Sogni, Philippe
    Pol, Stanislas
    GUT, 2018, 67 (01) : 197 - +
  • [30] HCV treatment with direct acting antivirals improves the insulin sensitivity
    Alsebaey, Ayman
    Elhelbawy, Mostafa
    Abdel-Razek, Wael
    Hashim, Mohammed
    Elshenawy, Hassan
    Waked, Imam
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (09) : 749 - 754
12345